Scott W. Morrison - Oct 6, 2022 Form 3 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Role
Director
Signature
/s/ Leonard M. Greenstein, Attorney-in-Fact
Stock symbol
TARS
Transactions as of
Oct 6, 2022
Transactions value $
$0
Form type
3
Date filed
10/11/2022, 04:20 PM
Previous filing
Oct 6, 2022
Next filing
May 12, 2023

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney